Jewish Senior Services Medicare and Medicaid Location: 4200 Park Avenue, Bridgeport, Connecticut 06604 Ratings: Phone: (203) 365-6400 |
Northbridge Health Care Center Medicare and Medicaid Location: 2875 Main Street, Bridgeport, Connecticut 06606 Ratings: Phone: (203) 336-0232 |
Springs At Watermark 3030 Park, The Medicare Location: 3030 Park Avenue, Bridgeport, Connecticut 06604 Ratings: Phone: (203) 374-5611 |
News Archive
An article written almost 30 years ago helps frame social constructs around the COVID-19 pandemic. By reviewing the essay, an historian of nursing at the University of Pennsylvania School of Nursing (Penn Nursing) extends that construct to include nurses and patients, delivering a local and personal meaning to the epidemic experience.
Karolinska Development (publ) have announced the formation of Pergamum AB, a company that will commercialize its dermatology and wound healing opportunities as associated business units within one company. Karolinska Development has transferred all of its holdings from its five dermatology and wound healing companies to Pergamum AB, owning 64% of the new company.
Among scientists specializing in the area, the mechanisms behind the signaling function of the Hedgehog (Hh) receptor pathway remain a mystery. Xiaoyen Zheng, Ph.D., assistant professor of anatomy and regenerative biology at the George Washington University School of Medicine and Health Sciences, who recently received a $1.7 million grant from the National Institutes of Health and National Institute of General Medical Sciences, is determined to learn more about the Hh pathway.
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it plans to begin the drug registration process in Brazil and Colombia for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in the United States under the brand name Cobroxin for the treatment of moderate to severe (Stage 2) chronic pain.
Researchers at The Jackson Laboratory, Cyteir Therapeutics and collaborating institutions have found a way to protect beta cells from destruction - achieving a longtime, elusive goal that could lead to therapies preventing type 1 diabetes (T1D).
› Verified 9 days ago